Bioimplants for Targeted Drug Delivery in Cancer Treatment and Reconstruction

Bioimplants for the Reconstructive Surgery and Local Delivery of Chemotherapeutic and Immunotherapeutic Agents

Authors: Anisimova N.Y., Martynenko N.S., Rybalchenko O.V., Senatov F.S., Straumal B.B., Enikeev N.A., Novruzov K.M., Kiselevskiy M.

Abstract:

Purpose:

This paper delve into the development and application of bioimplants that facilitate reconstructive surgeries, with an emphasis on their ability to locally deliver chemotherapeutic and immunotherapeutic agents. Bioimplants, engineered for this specific purpose, enable targeted therapy while minimizing systemic side effects by directly administering these drugs at the site of action.

Introduction:

The significance of bioimplants in contemporary medical practice is profound, particularly within oncology and reconstructive surgery fields. These implants are designed to improve therapeutic outcomes by precisely delivering drugs where they are most needed. highlights several aspects including their design, benefits over conventional drug delivery systems, clinical applications, and potential future advancements.

Design:

Bioimplants can be tlored using various materials such as polymeric carriers, metal matrices, and natural polymers like collagen or hyaluronic acid. Incorporation of drug release mechanisms enhances the precision of treatment by controlling the rate at which these drugs are released based on the specific needs of the surgical site. For instance, pH-sensitive polymers can trigger drug release under acidic conditions prevalent near tumors.

Benefits:

Compared to systemic delivery methods such as oral or intravenous administration, local drug delivery through bioimplants offers several advantages:

1. Reduced toxicity: By limiting exposure to drugs outside of targeted areas, systemic side effects are minimized.

2. Enhanced efficacy: Targeting the exact location of a tumor ensures that the highest concentration of therapeutic agents is present where they can most effectively inhibit or eliminate cancer cells.

Clinical Applications:

Several clinical applications showcase the potential impact of bioimplants:

1. Breast reconstruction after mastectomy could benefit from implants loaded with doxorubicin, a chemotherapy agent known for its efficacy agnst breast cancer.

2. Implants seeded with immune checkpoint inhibitors might enhance local anti-tumor immunity in melanoma or other solid tumors.

Future Advancements:

Ongoing research refine bioimplant technology by integrating more sophisticated drug delivery systems and biomaterials that can adaptively release drugs based on the dynamic conditions at the surgical site. Additionally, studies are exploring the use of nanotechnology to create miniaturized implants capable of precisely targeting cancer cells with unprecedented precision.

:

Bioimplants represent a promising advancement in personalized medicine by offering tlored therapies that combine reconstructive surgery and targeted drug delivery. Their development holds significant promise for improving patient outcomes while reducing side effects, making them an essential tool in contemporary oncology practice.

Keywords: Bioimplants, Reconstructive Surgery, Chemotherapy, Immunotherapy, Drug Delivery
This article is reproduced from: https://cobalt.colab.ws/?publisher_id=8&journal_id=62985

Please indicate when reprinting from: https://www.81le.com/Tumor_Cancer/Bioimplants_for_Reconstructive_Surgery_and_Drug_Delivery.html